The use of peptides to interfere with the interactions of proteins involved in cancer has been demonstrated successfully with iPeps comprising a conserved hexamotif and the N-terminus flanking sequence of the homeobox of the transcription factor Engrailed 1 (EN1) in basal-like breast cancer [18,19]. The gene discussed is EN1; the disease is breast carcinoma.